Skip to main content
Clinical Trials/ACTRN12615000862549
ACTRN12615000862549
Completed
未知

The use of MRI in radiotherapy planning to assess the feasibility of adaptive radiotherapy in gynaecological cancers.

Dr Karen Lim0 sites32 target enrollmentAugust 18, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Gynaecological Cancer
Sponsor
Dr Karen Lim
Enrollment
32
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 18, 2015
End Date
September 8, 2019
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Sponsor
Dr Karen Lim

Eligibility Criteria

Inclusion Criteria

  • Eligible patients will have a gynaecological cancer for which they have been recommended a course of radiotherapy to the pelvis, in addition to:
  • 1\. Aged older than 18 years
  • 2\. ECOG 0\-3
  • 3\. Histological diagnosis of malignant gynaecological tumour, including
  • a. Squamous cell carcinoma
  • b. Adenocarcinoma
  • c. Adenosquamous cell carcinoma
  • d. Endometrial carcinoma
  • e. Melanoma
  • f. Malignant mesenchymal tumours

Exclusion Criteria

  • 1\. Contraindication for MRI
  • a. Cardiac pacemaker or defibrillator
  • b. Non MRI compatible implants
  • i.Metal rod, screw or plate
  • ii Aneurysm clip
  • iii Artificial heart valve
  • iv Cochlear implant
  • v Intravascular stent
  • c. Non\-MRI compatible metallic foreign body
  • i Metallic fragment in the eye

Outcomes

Primary Outcomes

Not specified

Similar Trials